Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

FDA: Higher doses of tofacitinib tied to increased risks of death, pulmonary embolism
‘Never waste a good crisis’: Moving toward solutions for physician burnout
Editors-in-chief named for two new JACC journals
GE Healthcare IPO ‘unlikely’ in 2019, CEO says
Cardiovascular surgeons, invasive cardiologists are top revenue-generators for hospitals
Senators question drugmakers over rising insulin prices
Quality of CAD care higher for Medicare Advantage patients
Ultra-thin Orsiro stent gains FDA approval
How one center boosted palliative care use for advanced heart failure patients
Use of preventive cardiovascular drugs ‘markedly insufficient’ in China